Table 4.
Socio-demographic predictors of lifetime treatment contact for any anxiety disorder
| Country | Sex | χ2 | Cohort (age at interview) | χ2 | Age of onset | χ2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | Age 18-34 | Age 35-49 | Age 50-64 | Early | Early-average | Late-average | |||||||||||
| OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | ||||
| The Americas | |||||||||||||||||
| Colombia | 1.1 | (0.7-1.8) | 0.1 | 3.4 | (1.4-8.2) | 1.6 | (0.8-3.3) | 1.0 | - | 19.6 | 0.2 | (0.1-0.3) | 0.3 | (0.2-0.6) | 0.3 | (0.1-0.5) | 33.4 |
| Mexico | 1.1 | (0.6-1.8) | 0.1 | 2.3 | (0.8-6.4) | 2.3 | (0.8-6.4) | 1.0 | - | 12.6 | 0.2 | (0.1-0.3) | 0.2 | (0.1-0.3) | 0.2 | (0.1-0.3) | 59.1 |
| USA | 1.3 | (1.0-1.6) | 5.4 | 2.5 | (1.9-3.3) | 1.4 | (1.1-1.8) | 1.2 | (0.9-1.6) | 62.6 | 0.2 | (0.2-0.2) | 0.2 | (0.2-0.3) | 0.2 | (0.2-0.3) | 326.4 |
| Europe | |||||||||||||||||
| Belgium | 1.2 | (0.7-2.1) | 0.4 | 4.7 | (1.6-13.6) | 3.0 | (1.2-7.5) | 1.3 | (0.6-2.8) | 14.8 | 0.1 | (0.1-0.3) | 0.1 | (0.0-0.3) | 0.2 | (0.1-0.5) | 63.5 |
| France | 1.5 | (1.1-2.1) | 8.8 | 4.5 | (2.5-8.1) | 2.3 | (1.3-4.2) | 1.3 | (0.7-2.5) | 52.2 | 0.2 | (0.1-0.3) | 0.2 | (0.1-0.3) | 0.3 | (0.2-0.5) | 82.4 |
| Germany | 1.5 | (1.1-2.1) | 6.6 | 4.5 | (2.7-7.5) | 2.3 | (1.5-3.7) | 1.5 | (0.8-2.9) | 59.8 | 0.2 | (0.1-0.3) | 0.2 | (0.1-0.3) | 0.2 | (0.1-0.5) | 43.5 |
| Italy | 1.1 | (0.7-1.5) | 0.1 | 2.6 | (1.3-5.2) | 2.1 | (1.2-3.7) | 1.4 | (0.7-2.9) - | 16.0 | 0.1 | (0.1-0.2) | 0.1 | (0.1-0.2) | 0.3 | (0.2-0.5) | 101.8 |
| Netherlands | 1.1 | (0.7-1.6) | 0.2 | 3.0 | (1.8-5.1) | 2.5 | (1.6-3.7) | 1.0 | - | 26.8 | 0.1 | (0.0-0.2) | 0.1 | (0.1-0.3) | 0.4 | (0.2-0.7) | 52.0 |
| Spain | 1.0 | (0.7-1.6) | 0.0 | 3.3 | (1.9-5.7) | 2.0 | (1.1-3.7) | 0.8 | (0.5-1.3) | 38.5 | 0.1 | (0.0-0.1) | 0.1 | (0.0-0.2) | 0.2 | (0.1-0.4) | 96.2 |
| Africa and Middle East | |||||||||||||||||
| Israel | 1.0 | (0.6-1.5) | 0.0 | 5.0 | (1.8-13.9) | 3.2 | (1.4-7.4) | 1.9 | (0.9-4.0) | 10.0 | 0.4 | (0.2-1.0) | 0.5 | (0.3-1.1) | 0.6 | (0.3-1.2) | 3.7 |
| Lebanon | 0.5 | (0.2-1.2) | 2.5 | 1.9 | (0.2-20.0) | 1.3 | (0.1-11.3) | 0.8 | (0.1-6.9) | 12.6 | 0.1 | (0.0-0.3) | 0.2 | (0.1-0.4) | 0.7 | (0.3-1.5) | 28.7 |
| Nigeria | 1.1 | (0.4-3.3) | 0.0 | 0.6 | (0.1-3.0) | 0.1 | (0.0-0.7) | 0.3 | (0.1-1.9) | 17.9 | 0.3 | (0.2-0.7) | 0.6 | (0.2-2.0) | 0.5 | (0.2-1.5) | 10.1 |
| Asia and the Pacific | |||||||||||||||||
| Japan | 0.9 | (0.5-1.6) | 0.3 | 5.6 | (1.8-17.2) | 1.7 | (0.8-3.7) | 1.3 | (0.5-3.3) | 14.1 | 0.1 | (0.0-0.1) | 0.1 | (0.1-0.2) | 0.4 | (0.2-1.0) | 63.5 |
| PR China | 1.0 | (0.4-2.3) | 0.0 | 4.6 | (1.4-15.6) | 2.1 | (0.9-5.0) | 1.0 | - | 16.7 | 0.3 | (0.1-0.9) | 0.2 | (0.0-1.0) | 0.7 | (0.2-2.4) | 8.3 |
| Oceania | |||||||||||||||||
| New Zealand | 1.3 | (1.1-1.5) | 8.6 | 4.3 | (2.9-6.3) | 2.4 | (1.7-3.4) | 1.7 | (1.3-2.4) | 68.8 | 0.1 | (0.1-0.1) | 0.1 | (0.1-0.2) | 0.2 | (0.2-0.2) | 461.0 |